Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
AIDS Malignancy Consortium
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University of Nebraska
Novartis
Brigham and Women's Hospital
University of Cincinnati
Massachusetts Eye and Ear Infirmary
Merck Sharp & Dohme LLC
Cardiff University
Xiamen University
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Oslo University Hospital
SOLTI Breast Cancer Research Group
Ohio State University Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Centre Hospitalier Universitaire de Besancon
Shanghai Bovax Biotechnology Co., Ltd.
University of Cincinnati
Goethe University
Aarhus University Hospital
Aarhus University Hospital
Beijing Health Guard Biotechnology, Inc